SCHEMBL17826127

SCHEMBL17826127

C=C(c1ccc(-c2cncc(-c3nnc(NC4CCNCC4)o3)n2)cc1)N(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 7/20 0.59
▸ PIM1 P11309 4/20 0.41
▸ PIM2 Q9P1W9 4/20 0.41
▸ PIM3 Q86V86 2/20 0.41
▸ CYP1A2 P05177 4/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ USP2 O75604 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CYP2C9 P11712 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.38
▸ DYRK1A Q13627 5/20 0.37
▸ CLK2 P49760 2/20 0.37
▸ CLK3 P49761 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ GSK3B P49841 3/20 0.36
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17826167 0.90 ATR (0.57) ATRPIM1PIM2PIM3HSD17B10
SCHEMBL16420463 0.89 ATR (0.73) ATRPIM1PIM2CYP1A2HSD17B10
SCHEMBL17826113 0.82 ATR (0.52) ATR
SCHEMBL16420575 0.79 ATR (0.73) ATR
SCHEMBL17826204 0.78 ATR (0.56) ATRALDH1A1KDM4EHPGDLMNA
SCHEMBL17826140 0.78 ATR (0.53) ATRPIM1PIM2ALDH1A1KDM4E
SCHEMBL16420714 0.77 ATR (0.73) ATRPIM1PIM2PIM3
SCHEMBL17826112 0.77 ATR (0.55) ATRPIM1PIM2KDM4EGSK3B
SCHEMBL17826117 0.76 ATR (0.57) ATRALDH1A1KDM4EHPGDGSK3B
SCHEMBL17826123 0.75 ATR (0.57) ATRPIM1PIM2PIM3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365557-B2 Substituted pyrazin-2-amines as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-06-14 — — US disclosed
Send feedback